日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report

根据外部证据调整正在进行的 RAMPART 试验的设计:一个需要多年运行和报告的试验的案例

Meade, Angela; Frangou, Elena; Choodari-Oskooei, Babak; Larkin, James; Powles, Tom; Stewart, Grant D; Albiges, Laurence; Bex, Axel; Choueiri, Toni K; Davis, Ian D; Eisen, Tim; Fielding, Alison; Gedye, Craig; Harrison, David J; Kaplan, Rick; Mulhere, Salena; Nathan, Paul; Patel, Grisma; Patel, Jay; Plant, Hannah; Ritchie, Alastair; Rush, Hannah; Shakeshaft, Clare; Stockler, Martin R; Suarez, Cristina; Thompson, Jemima; Thorogood, Nat; Venugopal, Balaji; Parmar, Mahesh K B

RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse

RAMPART:一项针对接受手术切除的原发性肾细胞癌 (RCC) 高危或中危复发患者的辅助免疫检查点抑制剂 III 期多臂多阶段试验

Oza, Bhavna; Frangou, Eleni; Smith, Ben; Bryant, Hanna; Kaplan, Rick; Choodari-Oskooei, Babak; Powles, Tom; Stewart, Grant D; Albiges, Laurence; Bex, Axel; Choueiri, Toni K; Davis, Ian D; Eisen, Tim; Fielding, Alison; Harrison, David; McWhirter, Anita; Mulhere, Salena; Nathan, Paul; Rini, Brian; Ritchie, Alastair; Scovell, Sarah; Shakeshaft, Clare; Stockler, Martin R; Thorogood, Nat; Parmar, Mahesh K B; Larkin, James; Meade, Angela

RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting

RAMPART:肾细胞癌辅助治疗领域中符合监管要求的学术主导型 III 期临床试验模型

Meade, Angela; Oza, Bhavna; Frangou, Eleni; Smith, Ben; Bryant, Hanna; Kaplan, Rick; Choodari-Oskooei, Babak; Powles, Tom; Stewart, Grant D; Albiges, Laurence; Bex, Axel; Choueiri, Toni K; Davis, Ian D; Eisen, Tim; Fielding, Alison; Harrison, David J; McWhirter, Anita; Mulhere, Salena; Nathan, Paul; Rini, Brian; Ritchie, Alastair; Scovell, Sarah; Shakeshaft, Clare; Stockler, Martin R; Thorogood, Nat; Larkin, James; Parmar, Mahesh K B